Nasdaq Is To Takeover Adenza, Catalent Reports Q3 Loss: Market Updates
- June 12th, 2023
- 327 views
Nasdaq, Inc. (Nasdaq: NDAQ) has announced a definitive agreement to acquire Adenza, a leading provider of risk management and regulatory software to the financial services industry, from Thoma Bravo for a total consideration of $10.5 billion in cash and common stock.
The addition of Adenza's software and technology solutions enhances Nasdaq's liquidity and integrity platforms, boosting its Solutions Businesses' organic revenue growth outlook by 100 basis points to 8-11%. With a loyal and expanding client base, Adenza contributes to Nasdaq's revenue retention rates and increases the Solutions Businesses' share to 77% of total revenue. Moreover, this acquisition expands Nasdaq's serviceable addressable market by approximately 40%, representing a $10 billion growth opportunity.
The transaction is expected to result in the appointment of Holden Spaht, a Managing Partner at Thoma Bravo, to Nasdaq's expanded twelve-member Board of Directors.
As of pre-market, $NDAQ is trading at $53.50, experiencing a decrease of $4.33 (-7.49%) following the announcement.
Catalent, Inc. (NYSE: CTLT) released its financial results for the third quarter of fiscal year 2023, reporting an adjusted loss of $0.09 per share, which was higher than the consensus loss of $0.03 per share.
The company has revised its revenue guidance for the full fiscal year 2023, with expectations now set between $4.225 billion and $4.325 billion, slightly lower than the previous guidance range of $4.25 billion to $4.35 billion.
In pre-market trading, $CTLT is showing positive momentum, trading at $39.50 with a gain of $0.69 (+1.78%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025




Member Login